Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLowDOWN study of sitagliptin on bone measures in women with type 2 diabetes mellitus
2018-000859-40Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Tesavel + metformin with Placebo + metformin (2 arms). Primary endpoint: Change in bone mineral density at week 52. Started Jun 2021; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-000859-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000859-40.